Kelvin Chou is a Neurology physician affiliated with University of Michigan. OpenAlex indexes 201 publications with 5,739 citations (h-index 42).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4260 Plymouth Rd
Ann Arbor, MI 481092700
Telephone
734-764-6831Registry record last updated 16 Apr 2015.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202526 payments$17,925openpaymentsdata.cms.gov ↗
- Neurocrine BioSciences, Inc.Program year20257 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
95.6%Aromatic Amino Acid Decarboxylation Inhibitor48.7%Carbidopa-Levodopa77%Carbidopa-Levodopa Er16%Rytary5%Carbidopa3%Part D<11 patientsNonergot Dopamine Agonist10.8%Pramipexole Dihydrochloride55%Ropinirole Er27%Ropinirole Hcl18%Part D≥23 patients+ 13 more classes in this area
Cardiovascular
3.5%Beta blocker3.5%Propranolol Hcl Er68%Propranolol Hcl32%Part D<11 patientsMusculoskeletal
0.9%gamma-Aminobutyric Acid-ergic Agonist0.9%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2008–2022 per NIH RePORTER. The latest:
- NeuroNEXT Clinical Research Site at the University of Michigan
University of Michigan at Ann Arbor
FY2022$312,000U24NS107158 - NeuroNEXT Clinical Research Site at the University of Michigan
University of Michigan at Ann Arbor
FY2021$312,000U24NS107158 - NeuroNEXT Clinical Research Site at the University of Michigan
University of Michigan at Ann Arbor
FY2020$312,000U24NS107158
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study over 12 months
npj Parkinson s Disease
2024 - Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
npj Parkinson s Disease
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Matthias Kretzler, MD
University of Michigan
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”